IL1A and Alzheimer disease: This supports the idea that microglia activation and elevated IL-1α expression may contribute to the accumulation of APP and apoE, two key proteins known to be important for increasing the risk of AD pathology (see [6], for review), and that this will primarily take place in the APOE ε4/ε4 brain.